Interleukin-1β Inhibition for Chronic Kidney Disease in Obese Mice With Type 2 Diabetes

Inflammasome-driven release of interleukin(IL)-1β is a central element of many forms of sterile inflammation and has been evident to promote the onset and progression of diabetic kidney disease. We microdissected glomerular and tubulointerstitial samples from kidney biopsies of patients with diabeti...

Descripción completa

Detalles Bibliográficos
Autores principales: Lei, Yutian, Devarapu, Satish K., Motrapu, Manga, Cohen, Clemens D., Lindenmeyer, Maja T., Moll, Solange, Kumar, Santhosh V., Anders, Hans-Joachim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6549251/
https://www.ncbi.nlm.nih.gov/pubmed/31191559
http://dx.doi.org/10.3389/fimmu.2019.01223

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6549251/
https://www.ncbi.nlm.nih.gov/pubmed/31191559
http://dx.doi.org/10.3389/fimmu.2019.01223

Ejemplares similares